An improved, industrially viable, environment friendly and economically significant process for preparation of Ticagrelor is disclosed alongwith novel intermediates for the Ticagrelor synthesis.

The invention discloses an improved process for preparing Rebamipide with high purity and high yield. The Rebamipide is used as a medicament for treating gastric ulcer and the like. Generally, the process comprises subjecting carbostyrildiacid and/or its ester and/or its salt compound of formula (IV) containing th...

Discloses novel crystalline forms of 2-[4-(2-Oxo-cyclopentylmethyl)-phenyl]-propionic acid (Formula n) and its sodium derivatives (Formula I) and the process for preparation thereof A crystalline form SI of 2-[4-(2-Oxo-cyclopentylmethyl)-phenyl]-propionic acid (Formula H) characterized by XRD 20 at about 14.3°, 16.5...

The instant invention discloses a process for the preparation of Lurasidone Hydrochloride preparation with lesser impurity profile comprises of isolating Lurasidone base as a solid whereby subjecting the base with isopropyl alcohol-hydrochloric acid.

ABSTRACT: The present invention relates to a novel salt of (3aR,4S,7R,7aS)-2-[((1R,2R)-2-{[4-(1,2-benzisothiazol-3-yl)-piperazin-1-yl]methyl}cyclohexyl)methyl]hexahydro-1H-4,7-methanisoindol-1,3-dione and hydrates thereof, to methods for preparing the novel salt and its hydrates.

Disclosed are synthetic processes to produce phosphate salt of Cinacalcet unsaturated free base with a high degree of purity, and thereby producing Cinacalcet hydrochloride of very high purity by employing the above said intermediate along with an improved solvent system.

A novel process of preparing a dexibuprofen pharmaceutical formulation in the form of granules, which can be directly compressed into tablets. The process consists of two steps: (i) preparation of base granule, and (ii) blending of base granules with compression aid to get ready to compress granules, wherein the pro...

Disclosed is the process suitable for industrial synthesis of Pregabalin from (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic using sodium hypochlorite with low ash content by means of reverse addition.

An improved process for the preparation of Tenofovir disoproxil Fumarate using Wittig reagents as phase transfer catalyst.